Bio-Gene Technology Limited (ASX:BGT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0370
+0.0020 (5.71%)
Mar 4, 2026, 1:09 PM AEST
Market Cap10.68M +20.5%
Revenue (ttm)n/a
Net Income-2.52M
EPS-0.01
Shares Out305.06M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume137,119
Average Volume80,149
Open0.0390
Previous Close0.0350
Day's Range0.0370 - 0.0400
52-Week Range0.0160 - 0.0610
Beta0.85
RSI66.15
Earnings DateMar 5, 2026

About Bio-Gene Technology

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol BGT
Full Company Profile

Financial Performance

Financial Statements